Lexeo Therapeutics Inc. (NASDAQ: LXEO) is -14.23% lower on its value in year-to-date trading and has touched a low of $9.00 and a high of $22.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXEO stock was last observed hovering at around $11.62 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $11.51, the stock is -3.48% and -13.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing -0.95% at the moment leaves the stock -18.99% off its SMA200. LXEO registered a loss of -22.60% in past 6-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -11.87% gain in the last 1 month and extending the period to 3 months gives it a -30.79%, and is -4.48% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.09% over the week and 7.21% over the month.
Lexeo Therapeutics Inc. (LXEO) has around 58 employees, a market worth around $380.52M and $0.00M in sales. Distance from 52-week low is 27.89% and -48.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.60%).
The EPS is expected to grow by 77.51% this year.
Lexeo Therapeutics Inc. (LXEO) Top Institutional Holders
The shares outstanding are 26.65M, and float is at 21.94M with Short Float at 8.82%.
Lexeo Therapeutics Inc. (LXEO) Insider Activity
The most recent transaction is an insider sale by Townsend Richard Nolan,the company’sChief Executive Officer. SEC filings show that Townsend Richard Nolan sold 5,000 shares of the company’s common stock on Aug 12 ’24 at a price of $11.53 per share for a total of $57634.0. Following the sale, the insider now owns 0.12 million shares.
Lexeo Therapeutics Inc. disclosed in a document filed with the SEC on Jul 11 ’24 that Townsend Richard Nolan (Chief Executive Officer) sold a total of 28,031 shares of the company’s common stock. The trade occurred on Jul 11 ’24 and was made at $17.07 per share for $0.48 million. Following the transaction, the insider now directly holds 0.12 million shares of the LXEO stock.
Still, SEC filings show that on Jul 10 ’24, Townsend Richard Nolan (Chief Executive Officer) disposed off 26,969 shares at an average price of $16.50 for $0.44 million. The insider now directly holds 148,726 shares of Lexeo Therapeutics Inc. (LXEO).
